Publications by the researcher in collaboration with RAFAEL SAN JUAN GARRIDO (139)

2026

  1. Diagnostic Performance of Two Different Techniques to Quantify CMV-Specific Cell-Mediated Immunity in Intermediate-Risk Seropositive Kidney Transplant Recipients

    Transplant Infectious Disease, Vol. 28, Núm. 1

  2. Epidemiology and Risk Factors for Infection in Multiple Myeloma Patients Treated With Bispecific Antibodies

    Open Forum Infectious Diseases, Vol. 13, Núm. 8

  3. Evaluation of an Immune-guided Prevention Strategy Against CMV Among Intermediate-risk Kidney Transplant Recipients: A Quasi-experimental Study

    Transplantation, Vol. 110, Núm. 6, pp. e1265-e1275

  4. False-positive results of the turbidimetric β-D-glucan assay in patients with bacteremia

    Diagnostic Microbiology and Infectious Disease, Vol. 114, Núm. 3

  5. Infectious Complications in Living Donation Versus Donation After Brain Death Kidney Transplantation

    Transplant Infectious Disease

  6. Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of clostridioides difficile infection in patients receiving systemic antibiotic therapy (PREVAN trial)

    JAC-Antimicrobial Resistance, Vol. 8, Núm. 2

  7. Real-life experience with maribavir for the treatment of cytomegalovirus infection in solid organ transplant recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 44, Núm. 5

  8. Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice

    Mycoses, Vol. 69, Núm. 2

2025

  1. Breakthrough Invasive Mold Infections in Hematologic Cases: Relevance of the Host's Factors

    Open Forum Infectious Diseases, Vol. 12, Núm. 2

  2. CTLA4 Single-Nucleotide Polymorphisms Influence the Risk of HSV and VZV Infection in Kidney Transplant Recipients: A Prospective Cohort Study

    Transplant International, Vol. 38

  3. Human Cytomegalovirus Infection Induces Long-Term Changes in the Cytokine Milieu of Kidney Transplant Recipients

    Journal of Medical Virology, Vol. 97, Núm. 1

  4. Infection Risk in Older Kidney Transplant Recipients: An Analysis in the Era of Expanded Age Limits

    Transplant International, Vol. 38

  5. Knowledge and Adherence to Lifestyle Habits to Prevent Complications Associated With Immunosuppression in Kidney Transplant Recipients: A Single-Center Survey

    Transplant Infectious Disease, Vol. 27, Núm. 4

  6. Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.

    Transplantation Reviews, Vol. 39, Núm. 3

  7. Optimizando la adherencia al cribado de infección latente tuberculosa entre receptores de trasplante renal

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 38, Núm. 3, pp. 222-227

2024

  1. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

  2. Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin

    Transplant Infectious Disease, Vol. 26, Núm. 6

  3. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation

    American Journal of Transplantation, Vol. 24, Núm. 7, pp. 1180-1192

  4. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

  5. Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients

    Transplant Infectious Disease, Vol. 26, Núm. 6